Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th

Small Cap Growth Virtual Investor Conference Agenda Announced for October 16th

Virtual Investor Conferences, the leading proprietary investor conference series announced the agenda for the Small Cap Growth Virtual Investor Conference to be held October 16 th .

Individual investors, institutional investors, advisors, and analysts are invited to attend.

REGISTER HERE

It is recommended that investors pre-register and run the online system check to expedite participation and receive event updates. There is no cost to log-in, attend live presentations, or schedule 1x1 meetings with management.

Please schedule 1x1 meetings here

"We are proud to highlight a diverse and innovative roster of companies at our Small Cap Growth Virtual Investor Conference this week," said Jason Paltrowitz, Executive Vice President of Corporate Services at OTC Markets Group. "A special thanks to our issuers and investors for their ongoing engagement on this platform."

October 16 th

Eastern
Time (ET)
Presentation Ticker(s)
9:30 AM ET Crushmetric AQSE: CUSH
10:00 AM ET Zapp Electric Vehicles Group Limited OTCQB: ZAPPF
10:30 AM ET Hillcrest Energy Technologies Inc. OTCQB: HLRTF | CSE: HEAT
11:00 AM ET Equipmake Holdings AQSE: EQIP
11:30 AM ET Royalties Inc. OTCQID: ROYIF | CSE: RI
12:30 PM ET BacTech Environmental Corporation OTCQB: BCCEF | CSE: BAC
1:00 PM ET Perimeter Medical Imaging AI, Inc. OTCQX: PYNKF | TSXV: PINK
1:30 PM ET Panel – North American Cross-Trading Opportunities at a Glance
2:00 PM ET Sulnox Group plc OTCQX: SNOXF | AQSE: SNOX
2:30 PM ET Abitibi Metals Corp. OTCQB: AMQFF | CSE: AMQ
3:00 PM ET Rocket Doctor AI Inc. OTCQB: AIRDF | CSE: AIDR
3:30 PM ET Tartisan Nickel Corp. OTCQB: TTSRF | CSE: TN
4:00 PM ET Pharmala Biotech Holdings Inc. OTCQB: MDXXF | CSE: MDMA
4:30 PM ET Falconedge AQSE: EDGE


To facilitate investor relations scheduling and to view a complete calendar of Virtual Investor Conferences, please visit www.virtualinvestorconferences.com .

About Virtual Investor Conferences ®

Virtual Investor Conferences (VIC) is the leading proprietary investor conference series that provides an interactive forum for publicly traded companies to seamlessly present directly to investors.

Providing a real-time investor engagement solution, VIC is specifically designed to offer companies more efficient investor access. Replicating the components of an on-site investor conference, VIC offers companies enhanced capabilities to connect with investors, schedule targeted one-on-one meetings and enhance their presentations with dynamic video content. Accelerating the next level of investor engagement, Virtual Investor Conferences delivers leading investor communications to a global network of retail and institutional investors.

Media Contact:
OTC Markets Group Inc. +1 (212) 896-4428, media@otcmarkets.com

Virtual Investor Conferences Contact:
John M. Viglotti
SVP Corporate Services, Investor Access
OTC Markets Group
(212) 220-2221
johnv@otcmarkets.com


Primary Logo

News Provided by GlobeNewswire via QuoteMedia

MDMA:CNX
The Conversation (0)
Quantum Biopharma

Quantum BioPharma Announces Cash Reward of up to USD $7Million for Proof of Market Manipulation in its Stock

Reward to be Paid if Information Contributes Significant Evidence Leading to a Trial Victory or Settlement in Landmark USD $700 Million+ Lawsuit

Quantum BioPharma Ltd. (NASDAQ: QNTM) (CSE: QNTM) (FRA: 0K91) (“Quantum BioPharma” or the “Company”), a biopharmaceutical company dedicated to building a portfolio of innovative assets and biotech solutions for the treatment of challenging neurodegenerative and metabolic disorders and alcohol... Keep Reading...
Imagion Biosystems

Phase 2 HER2 Clinical Trial Manufacturing Commenced, WSU Imaging Optimisation Program Underway

Imagion Biosystems (ASX: IBX) (Company or Imagion), a company dedicated to improving healthcare outcomes through the early detection of cancer utilising its proprietary MagSense® imaging technology, is pleased to provide shareholders with a progress update regarding the Company’s business and... Keep Reading...
Stethoscope on stacked gold coins, symbolizing healthcare costs or medical finance.

Trump Tariffs to Raise US Medical Device Costs, Hospitals Hold Off on Stockpiling

President Donald Trump’s new round of tariffs —this time targeting copper— has intensified concerns about rising costs across key sectors, including healthcare. But despite significant price pressures on steel, aluminum, and now copper, all vital to medical device production, there is no... Keep Reading...
Actinogen

Actinogen confirms 100th participant in XanaMIA phase 2b/3 Alzheimer’s disease trial and interim analysis timeline

Actinogen Medical ASX: ACW (“ACW” or “the Company”) is pleased to announce that the 100th participant in its pivotal XanaMIA phase 2b/3 randomized trial of Xanamem® for Alzheimer’s disease (AD) has now passed all screening tests and is scheduled for randomization and treatment in July. This... Keep Reading...
Emyria Limited

Medibank to Fund Emyria’s PTSD Program at Perth Clinic

Emyria Limited (ASX: EMD) (“Emyria”, or the “Company”) a leader in developing and delivering innovative mental health treatments, is pleased to announce that Medibank Private Limited (“Medibank”), Australia’s largest private health insurer, has commenced funding for eligible customers to access... Keep Reading...
ASX:HIQ

HITIQ Announces Exclusive Global Agreement with Shock Doctor for PROTEQT Instrumented Mouthguard

Common Shareholder Questions – Entitlement Offer

HITIQ Limited (ASX: HIQ) (HITIQ or the Company), a pioneer in concussion management, proudly announces an exclusive global agreement with Shock Doctor, the world’s leading mouthguard innovator. This landmark agreement marks Shock Doctor’s two-year effort to design a mouthguard that will... Keep Reading...

Latest Press Releases

Related News